cKIT Mutation Screening Exons 9 11 13 17 AML
Introduction
The cKIT Mutation Screening Exons 9 11 13 17 AML is a crucial diagnostic test designed to identify specific genetic mutations associated with Acute Myeloid Leukemia (AML). Understanding these mutations is essential for determining the best treatment options and predicting patient outcomes. By detecting alterations in the cKIT gene, healthcare providers can tailor therapies to improve patient care.
What the Test Measures
This test specifically measures mutations in the cKIT gene across Exons 9, 11, 13, and 17. These mutations are known to play a significant role in the pathogenesis of AML, influencing both the disease’s behavior and response to treatment.
Who Should Consider This Test
Patients diagnosed with Acute Myeloid Leukemia or those exhibiting symptoms such as fatigue, fever, and frequent infections should consider this test. Additionally, individuals with risk factors like previous chemotherapy, exposure to certain chemicals, or a family history of blood disorders may benefit from screening.
Benefits of Taking the Test
- Provides critical information for personalized treatment plans.
- Helps in predicting disease progression and patient prognosis.
- Guides healthcare providers in selecting targeted therapies.
- Enables better management of AML symptoms and complications.
Understanding Your Results
Results are typically available within 7-8 days. A positive result indicates the presence of a mutation, which may require specific therapeutic strategies. It is essential to discuss your results with a healthcare provider to understand their implications fully.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| cKIT Mutation Screening Exons 9 11 13 17 AML | 15,000 KSh | 20,000 KSh |
Booking Information
We have branches across Kenya, including Nairobi, Mombasa, and Kisumu, to provide convenient access to our testing services. We also offer home sample collection for your convenience. To book the cKIT Mutation Screening Exons 9 11 13 17 AML test, please call or WhatsApp us at +254711564616.
Pre-Test Instructions
Please note that the cKIT Mutation Screening can be performed with a Doctor’s prescription. This prescription is not applicable for patients undergoing surgery, those who are pregnant, or individuals planning to travel abroad.
Sample Type and Method
The test is conducted using a peripheral blood sample (2ml of EDTA blood) and utilizes the Sanger Sequencing method to ensure accurate detection of mutations.
Take charge of your health today by booking the cKIT Mutation Screening Exons 9 11 13 17 AML test at DNA Labs Kenya!
